Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Energy Recovery | ERII | Nov 19, 2024 | 15.35 | +4.71 |
Energy Select Sector SPDR | XLE | Nov 19, 2024 | 95.38 | -0.64 |
Energy Services of America | ESOA | Nov 19, 2024 | 15.09 | +4.65 |
Energy Transfer L.P | ET-I | Nov 19, 2024 | 12.17 | +1.50 |
Energy Transfer LP Unit | ET | Nov 19, 2024 | 17.96 | +2.16 |
Energy Transfer Pref E | ET-E | Nov 19, 2024 | 25.00 | 0.00 |
Energy Vault | NRGV | Nov 19, 2024 | 1.61 | +11.03 |
Enerpac Tool Group | EPAC | Nov 19, 2024 | 47.11 | -0.30 |
EnerSys | ENS | Nov 19, 2024 | 94.11 | -2.10 |
Enfusion | ENFN | Nov 19, 2024 | 9.64 | -0.62 |
Engene | ENGN | Nov 19, 2024 | 7.52 | -1.83 |
ENGlobal | ENG | Nov 19, 2024 | 1.32 | +2.65 |
Enhabit | EHAB | Nov 19, 2024 | 7.27 | +1.82 |
Enhanced Short-Maturity Strgy ETF Pimco | MINT | Nov 19, 2024 | 100.56 | +0.03 |
Eni ADR | E | Nov 19, 2024 | 29.07 | -2.84 |
Enlight Renewable Energy | ENLT | Nov 19, 2024 | 16.31 | -0.55 |
Enlink Midstream LLC Unit | ENLC | Nov 19, 2024 | 15.60 | 0.00 |
Enliven Therapeutics | ELVN | Nov 19, 2024 | 26.18 | +5.14 |
Enlivex Therapeutics | ENLV | Nov 19, 2024 | 1.03 | -1.90 |
Ennis | EBF | Nov 19, 2024 | 20.86 | -0.95 |
Enova International | ENVA | Nov 19, 2024 | 100.28 | +0.33 |
Enovis | ENOV | Nov 19, 2024 | 45.27 | -0.59 |
Enovix | ENVX | Nov 19, 2024 | 8.93 | +4.32 |
Enphase Energy | ENPH | Nov 19, 2024 | 61.36 | -1.67 |
Enpro | NPO | Nov 19, 2024 | 173.50 | +2.05 |
Enservco | ENSV | Nov 19, 2024 | 0.06 | -8.33 |
Enstar Group | ESGR | Nov 19, 2024 | 323.82 | +0.03 |
Enstar Group Depository E Pref | ESGRO | Nov 19, 2024 | 19.92 | +0.15 |
Enstar Pref | ESGRP | Nov 19, 2024 | 19.55 | -1.11 |
Ensysce Biosciences | ENSC | Nov 19, 2024 | 0.68 | -0.32 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.